Julia K. Varga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julia K. Varga has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Ora Schueler-Furman
Hebrew University of Jerusalem
17 shared publications - Alisa Khramushin
Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland
4 shared publications - Aimiliani Konstantinou
Department of Chemistry for Life Sciences, Uppsala University, Husargatan 3, Box 576, 751 23 Uppsala, Sweden
3 shared publications - Jakob Nilsson
Center for Epigenetic Cell Memory, Danish Cancer Institute, Copenhagen, Denmark.
3 shared publications - Leandro Simonetti
Department of Chemistry - BMC, Uppsala University, Uppsala, Sweden
3 shared publications Manoj Kumar
Department of Biochemistry, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, The Hebrew University of Jerusalem
3 shared publications
Latest Publications
- Open Access
An Atlas of Short Linear Motif-Mediated Human Protein-Protein Interactions
Short linear motifs (SLiMs) within intrinsically disordered protein regions mediate transient interactions crucial for cell physiology 1 . However, the global interaction landscape of human SLiMs remains largely uncharted. Here we present the Atlas of SLiM-mediated Human protein-protein Interactions (ASHI), which maps more than 20,000 interactions by screening over 800 human protein domains against a library of one million peptides tiling the human disordered proteome. ASHI expands the SLiM interactome, uncovers novel binding modes for known peptide-binding domains, and reveals unexpected peptide-binding activities in enzymes, chaperones, RNA-binding proteins, and modification-reader domains. Furthermore, intrinsically disordered regions emerge as densely encoded interaction platforms where interaction specificity is governed by diverse mechanisms, including key motif determinants, flanking residues, competition, and multivalency. These data provide an unprecedented foundation for modeling dynamic interaction networks, interpreting disease-associated variants, and decoding the dark proteome.
Open AccessAn Atlas of Short Linear Motif-Mediated Human Protein-Protein Interactions
Short linear motifs (SLiMs) within intrinsically disordered protein regions mediate transient interactions crucial for cell physiology 1 . However, the global interaction landscape of human SLiMs remains largely uncharted. Here we present the Atlas of SLiM-mediated Human protein-protein Interactions (ASHI), which maps more than 20,000 interactions by screening over 800 human protein domains against a library of one million peptides tiling the human disordered proteome. ASHI expands the SLiM interactome, uncovers novel binding modes for known peptide-binding domains, and reveals unexpected peptide-binding activities in enzymes, chaperones, RNA-binding proteins, and modification-reader domains. Furthermore, intrinsically disordered regions emerge as densely encoded interaction platforms where interaction specificity is governed by diverse mechanisms, including key motif determinants, flanking residues, competition, and multivalency. These data provide an unprecedented foundation for modeling dynamic interaction networks, interpreting disease-associated variants, and decoding the dark proteome.
- Open Access
- 18 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Systematic discovery of motif-based interactions of the auxiliary domains of USP family deubiquitinases
The ubiquitin-specific proteases (USPs) family is the largest family of human deubiquitinating enzymes (DUBs). While most USPs are agnostic to polyubiquitin linkage-type, their substrate specificity is thought to be mediated by the recognition of the ubiquitnated protein itself. In addition to their catalytic domain, USPs have one or more auxiliary domains (ADs) with key functions in regulating DUB activity and localization. We hypothesize that some ADs bind short linear motifs (SLiMs) typically found in intrinsically disordered regions of proteins to achieve targeting to substrates and multiprotein complexes. To test this, we systematically assess the potential of 29 USP-ADs and two full-length USPs for SLiM binding using a combination of proteomic-peptide phage display, peptide SPOT arrays and affinity measurements. We discover SLiM-based interactions for 14 ADs from 9 USP-DUBs, including CYLD, USP11, USP19, USP20, USP22 and USP33, and define the consensus motif and properties of the SLiM-AD binding. Interestingly, we establish that the zf-UBP and DUSP2 domains of USP20 and USP33 are SLiM binding ADs with similar binding profiles, explaining the functional redundancy between the two DUBs. Our work reveals unique motifs recognized by the auxiliary domains CAP-Gly, UBL, zf-UBP and DUSP, with potential functional implications for substrate recognition and complex assemblies.
- 18 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSystematic discovery of motif-based interactions of the auxiliary domains of USP family deubiquitinases
The ubiquitin-specific proteases (USPs) family is the largest family of human deubiquitinating enzymes (DUBs). While most USPs are agnostic to polyubiquitin linkage-type, their substrate specificity is thought to be mediated by the recognition of the ubiquitnated protein itself. In addition to their catalytic domain, USPs have one or more auxiliary domains (ADs) with key functions in regulating DUB activity and localization. We hypothesize that some ADs bind short linear motifs (SLiMs) typically found in intrinsically disordered regions of proteins to achieve targeting to substrates and multiprotein complexes. To test this, we systematically assess the potential of 29 USP-ADs and two full-length USPs for SLiM binding using a combination of proteomic-peptide phage display, peptide SPOT arrays and affinity measurements. We discover SLiM-based interactions for 14 ADs from 9 USP-DUBs, including CYLD, USP11, USP19, USP20, USP22 and USP33, and define the consensus motif and properties of the SLiM-AD binding. Interestingly, we establish that the zf-UBP and DUSP2 domains of USP20 and USP33 are SLiM binding ADs with similar binding profiles, explaining the functional redundancy between the two DUBs. Our work reveals unique motifs recognized by the auxiliary domains CAP-Gly, UBL, zf-UBP and DUSP, with potential functional implications for substrate recognition and complex assemblies.
- Open Access
Strategic template filtering accelerates fragment-based peptide docking
Peptide-protein interactions are often transient and structurally elusive, necessitating computational approaches to identify both binding sites and peptide conformations. PatchMAN, one of the leading but computationally expensive biophysic-based global peptide-docking protocols, addresses this challenge by treating peptide docking as a protein-folding problem, using structural motifs from solved structures as templates that are subsequently refined using Rosetta FlexPepDock. Here we present PatchMAN2, which introduces 1) strategic fragment filtering and 2) local docking modes that focus sampling on relevant surfaces or known binding regions, thereby reducing the high computational cost of the original implementation due to extensive refinement of many non-productive low-quality fragments. Benchmarking shows that PatchMAN2 removes ∼30-70% of unnecessary fragments while preserving accuracy, substantially reducing runtime and improving the practical efficiency of peptide-protein docking.
Open AccessStrategic template filtering accelerates fragment-based peptide docking
Peptide-protein interactions are often transient and structurally elusive, necessitating computational approaches to identify both binding sites and peptide conformations. PatchMAN, one of the leading but computationally expensive biophysic-based global peptide-docking protocols, addresses this challenge by treating peptide docking as a protein-folding problem, using structural motifs from solved structures as templates that are subsequently refined using Rosetta FlexPepDock. Here we present PatchMAN2, which introduces 1) strategic fragment filtering and 2) local docking modes that focus sampling on relevant surfaces or known binding regions, thereby reducing the high computational cost of the original implementation due to extensive refinement of many non-productive low-quality fragments. Benchmarking shows that PatchMAN2 removes ∼30-70% of unnecessary fragments while preserving accuracy, substantially reducing runtime and improving the practical efficiency of peptide-protein docking.
- Open Access
- 13 March 2026
- Vol. 27 (5) , e70237
Identification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational Modelling.
Interactions between peptides based on a region in the zinc finger translocation associated (ZFTA) protein and the Kelch domain of Kelch-like protein 20 (KLHL20Kelch) have been characterised by biosensor analysis, supported by AlphaFold2-based structure predictions of peptides bound to the protein. Residues critical for the interaction were identified. The analysis showed that all peptides exhibited relatively weak and complex interactions with KLHL20Kelch. The original ZFTA peptide had a much higher affinity for KLHL20Kelch than for the Kelch domain of KLHL12 (KLHL12Kelch), indicating a specificity for KLHL20Kelch. The estimated KD app of 35 µM was like that for a 21-mer peptide derived from death-associated protein kinase 1, a known KLHL20 substrate. Removal of flexible C-terminal residues generated a 12-mer, predicted to form a stable helix. This reduced the affinity 100-fold. Removal of N-terminal residues resulted in a 10-mer predicted to be flexible, which had a similar affinity as the original 16-mer. The similar affinities for peptides representing different regions of ZFTA suggest that the recognition is feature specific rather than sequence specific. The interaction mechanism reflects "fuzzy binding", consistent with the role of KLHL20 as an adaptor protein in the ubiquitination of disordered protein substrates by Cullin-3 E3 ubiquitin ligase.
- 13 March 2026
- Vol. 27 (5) , e70237
Open AccessIdentification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational Modelling.
Interactions between peptides based on a region in the zinc finger translocation associated (ZFTA) protein and the Kelch domain of Kelch-like protein 20 (KLHL20Kelch) have been characterised by biosensor analysis, supported by AlphaFold2-based structure predictions of peptides bound to the protein. Residues critical for the interaction were identified. The analysis showed that all peptides exhibited relatively weak and complex interactions with KLHL20Kelch. The original ZFTA peptide had a much higher affinity for KLHL20Kelch than for the Kelch domain of KLHL12 (KLHL12Kelch), indicating a specificity for KLHL20Kelch. The estimated KD app of 35 µM was like that for a 21-mer peptide derived from death-associated protein kinase 1, a known KLHL20 substrate. Removal of flexible C-terminal residues generated a 12-mer, predicted to form a stable helix. This reduced the affinity 100-fold. Removal of N-terminal residues resulted in a 10-mer predicted to be flexible, which had a similar affinity as the original 16-mer. The similar affinities for peptides representing different regions of ZFTA suggest that the recognition is feature specific rather than sequence specific. The interaction mechanism reflects "fuzzy binding", consistent with the role of KLHL20 as an adaptor protein in the ubiquitination of disordered protein substrates by Cullin-3 E3 ubiquitin ligase.
- Open Access
- 28 February 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (5) , e70237
Identification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational Modelling
Interactions between peptides based on a region in the zinc finger translocation associated (ZFTA) protein and the Kelch domain of Kelch‐like protein 20 (KLHL20 Kelch ) have been characterised by biosensor analysis, supported by AlphaFold2‐based structure predictions of peptides bound to the protein. Residues critical for the interaction were identified. The analysis showed that all peptides exhibited relatively weak and complex interactions with KLHL20 Kelch . The original ZFTA peptide had a much higher affinity for KLHL20 Kelch than for the Kelch domain of KLHL12 (KLHL12 Kelch ), indicating a specificity for KLHL20 Kelch . The estimated K D app of 35 µM was like that for a 21‐mer peptide derived from death‐associated protein kinase 1, a known KLHL20 substrate. Removal of flexible C‐terminal residues generated a 12‐mer, predicted to form a stable helix. This reduced the affinity 100‐fold. Removal of N‐terminal residues resulted in a 10‐mer predicted to be flexible, which had a similar affinity as the original 16‐mer. The similar affinities for peptides representing different regions of ZFTA suggest that the recognition is feature specific rather than sequence specific. The interaction mechanism reflects “fuzzy binding”, consistent with the role of KLHL20 as an adaptor protein in the ubiquitination of disordered protein substrates by Cullin‐3 E3 ubiquitin ligase.
- 28 February 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (5) , e70237
Open AccessIdentification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational Modelling
Interactions between peptides based on a region in the zinc finger translocation associated (ZFTA) protein and the Kelch domain of Kelch‐like protein 20 (KLHL20 Kelch ) have been characterised by biosensor analysis, supported by AlphaFold2‐based structure predictions of peptides bound to the protein. Residues critical for the interaction were identified. The analysis showed that all peptides exhibited relatively weak and complex interactions with KLHL20 Kelch . The original ZFTA peptide had a much higher affinity for KLHL20 Kelch than for the Kelch domain of KLHL12 (KLHL12 Kelch ), indicating a specificity for KLHL20 Kelch . The estimated K D app of 35 µM was like that for a 21‐mer peptide derived from death‐associated protein kinase 1, a known KLHL20 substrate. Removal of flexible C‐terminal residues generated a 12‐mer, predicted to form a stable helix. This reduced the affinity 100‐fold. Removal of N‐terminal residues resulted in a 10‐mer predicted to be flexible, which had a similar affinity as the original 16‐mer. The similar affinities for peptides representing different regions of ZFTA suggest that the recognition is feature specific rather than sequence specific. The interaction mechanism reflects “fuzzy binding”, consistent with the role of KLHL20 as an adaptor protein in the ubiquitination of disordered protein substrates by Cullin‐3 E3 ubiquitin ligase.
- Open Access
Systematic Discovery of Motif-based Interactions of the Auxiliary Domains of USP Family Deubiquitinases
The ubiquitin-specific proteases (USPs) family is the largest family of human deubiquitinating enzymes (DUBs). While most USPs are agnostic to polyubiquitin linkage-type, their substrate specificity is thought to be mediated by the recognition of the ubiquitylated protein itself. In addition to their catalytic domain, USPs have one or more auxiliary domains (ADs) with key functions in regulating DUB activity and subcellular localization. We hypothesize that some ADs bind short linear motifs (SLiMs) typically found in intrinsically disordered regions of proteins to achieve targeting to substrates and multiprotein complexes. To test this hypothesis, we systematically assessed the potential of 29 USP-ADs and two full-length USPs for SLiM binding using a combination of proteomic-peptide phage display, peptide arrays and affinity measurements. We discovered SLiM-based interactions for 14 ADs from 9 USP-DUBs, including CYLD, USP11, USP19, USP20, USP22 and USP33, and define the consensus motif and properties of the SLiM-AD binding. Interestingly, we established that the zf-UBP and DUSP2 domains of USP20 and USP33 are SLiM binding ADs with similar binding profiles, explaining the functional redundancy between the two DUBs. Our work reveals unique motifs recognized by the auxiliary domains CAP-Gly, UBL, zf-UBP and DUSP, with potential functional implications for substrate recognition and complex assemblies.
Open AccessSystematic Discovery of Motif-based Interactions of the Auxiliary Domains of USP Family Deubiquitinases
The ubiquitin-specific proteases (USPs) family is the largest family of human deubiquitinating enzymes (DUBs). While most USPs are agnostic to polyubiquitin linkage-type, their substrate specificity is thought to be mediated by the recognition of the ubiquitylated protein itself. In addition to their catalytic domain, USPs have one or more auxiliary domains (ADs) with key functions in regulating DUB activity and subcellular localization. We hypothesize that some ADs bind short linear motifs (SLiMs) typically found in intrinsically disordered regions of proteins to achieve targeting to substrates and multiprotein complexes. To test this hypothesis, we systematically assessed the potential of 29 USP-ADs and two full-length USPs for SLiM binding using a combination of proteomic-peptide phage display, peptide arrays and affinity measurements. We discovered SLiM-based interactions for 14 ADs from 9 USP-DUBs, including CYLD, USP11, USP19, USP20, USP22 and USP33, and define the consensus motif and properties of the SLiM-AD binding. Interestingly, we established that the zf-UBP and DUSP2 domains of USP20 and USP33 are SLiM binding ADs with similar binding profiles, explaining the functional redundancy between the two DUBs. Our work reveals unique motifs recognized by the auxiliary domains CAP-Gly, UBL, zf-UBP and DUSP, with potential functional implications for substrate recognition and complex assemblies.
- Open Access
- 4 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (40) , eadp5491
Substrate recognition principles for the PP2A-B55 protein phosphatase
The PP2A-B55 phosphatase regulates a plethora of signaling pathways throughout eukaryotes. How PP2A-B55 selects its substrates presents a severe knowledge gap. By integrating AlphaFold modeling with comprehensive high-resolution mutational scanning, we show that α helices in substrates bind B55 through an evolutionary conserved mechanism. Despite a large diversity in sequence and composition, these α helices share key amino acid determinants that engage discrete hydrophobic and electrostatic patches. Using deep learning protein design, we generate a specific and potent competitive peptide inhibitor of PP2A-B55 substrate interactions. With this inhibitor, we uncover that PP2A-B55 regulates the nuclear exosome targeting (NEXT) complex by binding to an α-helical recruitment module in the RNA binding protein 7 (RBM7), a component of the NEXT complex. Collectively, our findings provide a framework for the understanding and interrogation of PP2A-B55 function in health and disease.
- 4 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (40) , eadp5491
Open AccessSubstrate recognition principles for the PP2A-B55 protein phosphatase
The PP2A-B55 phosphatase regulates a plethora of signaling pathways throughout eukaryotes. How PP2A-B55 selects its substrates presents a severe knowledge gap. By integrating AlphaFold modeling with comprehensive high-resolution mutational scanning, we show that α helices in substrates bind B55 through an evolutionary conserved mechanism. Despite a large diversity in sequence and composition, these α helices share key amino acid determinants that engage discrete hydrophobic and electrostatic patches. Using deep learning protein design, we generate a specific and potent competitive peptide inhibitor of PP2A-B55 substrate interactions. With this inhibitor, we uncover that PP2A-B55 regulates the nuclear exosome targeting (NEXT) complex by binding to an α-helical recruitment module in the RNA binding protein 7 (RBM7), a component of the NEXT complex. Collectively, our findings provide a framework for the understanding and interrogation of PP2A-B55 function in health and disease.
- Open Access
Binding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition
SARS-CoV-2 infection triggers strong antibody response toward Nucleocapsid-Protein (NP), suggesting extracellular presence beyond its intra-virion RNA binding. Interestingly, NP was found to decorate infected and proximal uninfected cell-surfaces. Here, we propose a new mechanism through which extracellular NP on uninfected cells contributes to COVID-19 pathogenicity. We show that NP binds to cell-surface sulfated linear-glycosaminoglycans by spatial rearrangement of its RNA-binding sites facilitated by the flexible, positively charged, linker. Coating of uninfected lung-derived cells with purified NP attracted anti-NP-IgG from lung fluids and sera collected from COVID-19 patients. The magnitude of this immune recognition was significantly elevated in moderate compared to mild COVID-19 cases. Importantly, binding of anti-NP-IgG present in sera generated clusters that triggered C3b deposition by the classical complement pathway. Heparin analog enoxaparin outcompeted NP-binding, rescuing cells from anti-NP IgG-mediated complement deposition. Our findings unveil how extracellular NP may exacerbate COVID-19 tissue damage, and suggest leads for preventative therapy. Highlights IgG from patients’ sera target NP-bound cells resulting in complement activation The flexible linker allows NP to both bind linear sulfated GAGs and wrap around RNA Heparin analogs prevent NP surface binding and alleviate complement activation Cell-ELISA anti-NP IgG levels differ between mild and moderate COVID-19
Open AccessBinding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition
SARS-CoV-2 infection triggers strong antibody response toward Nucleocapsid-Protein (NP), suggesting extracellular presence beyond its intra-virion RNA binding. Interestingly, NP was found to decorate infected and proximal uninfected cell-surfaces. Here, we propose a new mechanism through which extracellular NP on uninfected cells contributes to COVID-19 pathogenicity. We show that NP binds to cell-surface sulfated linear-glycosaminoglycans by spatial rearrangement of its RNA-binding sites facilitated by the flexible, positively charged, linker. Coating of uninfected lung-derived cells with purified NP attracted anti-NP-IgG from lung fluids and sera collected from COVID-19 patients. The magnitude of this immune recognition was significantly elevated in moderate compared to mild COVID-19 cases. Importantly, binding of anti-NP-IgG present in sera generated clusters that triggered C3b deposition by the classical complement pathway. Heparin analog enoxaparin outcompeted NP-binding, rescuing cells from anti-NP IgG-mediated complement deposition. Our findings unveil how extracellular NP may exacerbate COVID-19 tissue damage, and suggest leads for preventative therapy. Highlights IgG from patients’ sera target NP-bound cells resulting in complement activation The flexible linker allows NP to both bind linear sulfated GAGs and wrap around RNA Heparin analogs prevent NP surface binding and alleviate complement activation Cell-ELISA anti-NP IgG levels differ between mild and moderate COVID-19
- Top Cited PapersOpen Access
- 15 January 2024
- Published by Springer Nature in Molecular Systems Biology
- Vol. 20 (2) , 75-97
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Structural resolution of protein interactions enables mechanistic and functional studies as well as interpretation of disease variants. However, structural data is still missing for most protein interactions because we lack computational and experimental tools at scale. This is particularly true for interactions mediated by short linear motifs occurring in disordered regions of proteins. We find that AlphaFold-Multimer predicts with high sensitivity but limited specificity structures of domain-motif interactions when using small protein fragments as input. Sensitivity decreased substantially when using long protein fragments or full length proteins. We delineated a protein fragmentation strategy particularly suited for the prediction of domain-motif interfaces and applied it to interactions between human proteins associated with neurodevelopmental disorders. This enabled the prediction of highly confident and likely disease-related novel interfaces, which we further experimentally corroborated for FBXO23-STX1B, STX1B-VAMP2, ESRRG-PSMC5, PEX3-PEX19, PEX3-PEX16, and SNRPB-GIGYF1 providing novel molecular insights for diverse biological processes. Our work highlights exciting perspectives, but also reveals clear limitations and the need for future developments to maximize the power of Alphafold-Multimer for interface predictions.
- 15 January 2024
- Published by Springer Nature in Molecular Systems Biology
- Vol. 20 (2) , 75-97
Top Cited PapersOpen AccessSystematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Structural resolution of protein interactions enables mechanistic and functional studies as well as interpretation of disease variants. However, structural data is still missing for most protein interactions because we lack computational and experimental tools at scale. This is particularly true for interactions mediated by short linear motifs occurring in disordered regions of proteins. We find that AlphaFold-Multimer predicts with high sensitivity but limited specificity structures of domain-motif interactions when using small protein fragments as input. Sensitivity decreased substantially when using long protein fragments or full length proteins. We delineated a protein fragmentation strategy particularly suited for the prediction of domain-motif interfaces and applied it to interactions between human proteins associated with neurodevelopmental disorders. This enabled the prediction of highly confident and likely disease-related novel interfaces, which we further experimentally corroborated for FBXO23-STX1B, STX1B-VAMP2, ESRRG-PSMC5, PEX3-PEX19, PEX3-PEX16, and SNRPB-GIGYF1 providing novel molecular insights for diverse biological processes. Our work highlights exciting perspectives, but also reveals clear limitations and the need for future developments to maximize the power of Alphafold-Multimer for interface predictions.
- Open Access
- 21 November 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (12) , e56920
Structural study of UFL1‐UFC1 interaction uncovers the role of UFL1 N‐terminal helix in ufmylation
Ufmylation plays a crucial role in various cellular processes including DNA damage response, protein translation, and ER homeostasis. To date, little is known about how the enzymes responsible for ufmylation coordinate their action. Here, we study the details of UFL1 (E3) activity, its binding to UFC1 (E2), and its relation to UBA5 (E1), using a combination of structural modeling, X‐ray crystallography, NMR, and biochemical assays. Guided by Alphafold2 models, we generate an active UFL1 fusion construct that includes its partner DDRGK1 and solve the crystal structure of this critical interaction. This fusion construct also unveiled the importance of the UFL1 N‐terminal helix for binding to UFC1. The binding site suggested by our UFL1‐UFC1 model reveals a conserved interface, and competition between UFL1 and UBA5 for binding to UFC1. This competition changes in the favor of UFL1 following UFM1 charging of UFC1. Altogether, our study reveals a novel, terminal helix‐mediated regulatory mechanism, which coordinates the cascade of E1‐E2‐E3‐mediated transfer of UFM1 to its substrate and provides new leads to target this modification.
- 21 November 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (12) , e56920
Open AccessStructural study of UFL1‐UFC1 interaction uncovers the role of UFL1 N‐terminal helix in ufmylation
Ufmylation plays a crucial role in various cellular processes including DNA damage response, protein translation, and ER homeostasis. To date, little is known about how the enzymes responsible for ufmylation coordinate their action. Here, we study the details of UFL1 (E3) activity, its binding to UFC1 (E2), and its relation to UBA5 (E1), using a combination of structural modeling, X‐ray crystallography, NMR, and biochemical assays. Guided by Alphafold2 models, we generate an active UFL1 fusion construct that includes its partner DDRGK1 and solve the crystal structure of this critical interaction. This fusion construct also unveiled the importance of the UFL1 N‐terminal helix for binding to UFC1. The binding site suggested by our UFL1‐UFC1 model reveals a conserved interface, and competition between UFL1 and UBA5 for binding to UFC1. This competition changes in the favor of UFL1 following UFM1 charging of UFC1. Altogether, our study reveals a novel, terminal helix‐mediated regulatory mechanism, which coordinates the cascade of E1‐E2‐E3‐mediated transfer of UFM1 to its substrate and provides new leads to target this modification.